Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study.

da Silva Sardenberg RA, de Campos CAL, Porto BC, da Cruz JAS

DOI: 10.1186/s12885-026-15702-2
Published: 2026 Mar 4
Container: BMC cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-15702-2,
  title = {Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study.},
  author = {da Silva Sardenberg RA and de Campos CAL and Porto BC and da Cruz JAS},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-15702-2},
  url = {https://doi.org/10.1186/s12885-026-15702-2}
}

RIS

TY  - JOUR
TI  - Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study.
AU  - da Silva Sardenberg RA
AU  - de Campos CAL
AU  - Porto BC
AU  - da Cruz JAS
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-15702-2
UR  - https://doi.org/10.1186/s12885-026-15702-2
ER  -

APA

RA, D. S. S., CAL, D. C., BC, P., & JAS, D. C. (2026). Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study.. BMC cancer. https://doi.org/10.1186/s12885-026-15702-2

Source records

pubmed · retrieved 2026-09-25T18:54:50.258Z